KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cvs Health (CVS) Deferred Taxes (2016 - 2024)

Cvs Health (CVS) has disclosed Deferred Taxes for 16 consecutive years, with -$217.0 million as the latest value for Q1 2024.

  • For the quarter ending Q1 2024, Deferred Taxes fell 240.0% year-over-year to -$217.0 million, compared with a TTM value of -$194.0 million through Mar 2024, up 88.58%, and an annual FY2024 reading of -$572.0 million, up 15.38% over the prior year.
  • Deferred Taxes was -$217.0 million for Q1 2024 at Cvs Health, up from -$316.0 million in the prior quarter.
  • Across five years, Deferred Taxes topped out at $243.0 million in Q4 2021 and bottomed at -$1.9 billion in Q3 2022.
  • Average Deferred Taxes over 5 years is -$225.3 million, with a median of -$166.0 million recorded in 2021.
  • The sharpest move saw Deferred Taxes plummeted 602.55% in 2022, then skyrocketed 188.57% in 2023.
  • Year by year, Deferred Taxes stood at -$545.0 million in 2020, then skyrocketed by 144.59% to $243.0 million in 2021, then fell by 24.28% to $184.0 million in 2022, then crashed by 271.74% to -$316.0 million in 2023, then soared by 31.33% to -$217.0 million in 2024.
  • Business Quant data shows Deferred Taxes for CVS at -$217.0 million in Q1 2024, -$316.0 million in Q4 2023, and $155.0 million in Q1 2023.